NCT03324932View on ClinicalTrials.gov

Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 25, 2017

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2027

Conditions
Breast Cancer
Interventions
DRUG

Denosumab Injection

AI intake + denosumab injection per 6 months VS only AI intake

Trial Locations (1)

6028566

Hisako Ono, Kyoto

All Listed Sponsors
lead

Kyoto Prefectural University of Medicine

OTHER